Global Bioelectric Medicine Market: Focus on Product, 11 Countries’ Data, and Competitive Landscape – Analysis and Forecast, 2019-2025
Hard copy option is available on any of the options above at an additional charge of $500. Please email us at [email protected] with your request.
Key Questions Answered in this Report:
The global bioelectric medicine industry analysis by BIS Research projects the market to grow at a significant CAGR of 6.41% during the forecast period, 2019-2025. The bioelectric medicine market generated $18,636.4 million revenue in 2018.
The bioelectric medicine growth has been primarily attributed to the major drivers such as growing geriatric population leads to surge in exigency of bioelectric medicine, increasing burden of diseases inciting the use of bioelectric medicine, growing investments and funds for the development of novel therapeutics and electroceuticals, limited success rate of drugs targeting specific disease, increasing amount of adverse drug reaction, and upsurge in awareness level. The market is expected to grow at a significant growth rate due to the opportunities that lie within its domain, which include growth in emerging countries and technological advancement in bioelectric medicine. However, there are significant challenges which are restraining the market growth. These challenges include product recall, exorbitant cost of electroceuticals, increased regulatory scrutiny, and complications and side effects associated with the bioelectric medicine devices.
Expert Quote
“The pacemaker represents the biggest opportunity in the bioelectric medicine market, as the demand of pacemaker and awareness of about the pacemakers are higher compare to other bioelectric medicine products. The upsurge prevalence of cardiovascular diseases and growing geriatric population has made it the largest sources of bioelectric medicine for the treatment of cardiovascular disorders.”
Scope of the Market Intelligence on Bioelectric Medicine Market
The bioelectric medicine market research provides a holistic view of the market in terms of various factors influencing it, regulatory reforms, and technological advancements. The scope of this report is centered upon detailed study of the products, associated with the market. In addition, the study also includes exhaustive information on the market needs, details on the new products, competitive landscape, market share of leading players, growth potential of each underlying sub-segment, and company, as well as other vital information with respect to the global bioelectric medicine market.
Market Segmentation
The bioelectric medicine market segmentation (on the basis of product type) is further segmented into implantable and non-implantable.
On the basis of implantable bioelectric medicine, the bioelectric medicine market is segmented into pacemaker, ICDs, spinal cord stimulation devices, cochlear implant, deep brain stimulation device, vagus nerve stimulation device, and others.
Key Companies in the Bioelectric Medicine Industry
The key manufacturers that have been contributing significantly to the bioelectric medicine market include Abbott Laboratories, Boston Scientific Corporation, Cochlear Limited, electroCore, Inc., Inspire Medical Systems, Inc., LivaNova PLC, Medtronic Plc, Nevro Corp., Nuvectra Corporation, NeuroMetrix, Inc., OMRON CORPORATION, PIXIUM VISION, Second Sight Medical Products, Inc., BIOTRONIK SE & Co. KG, MED-EL, SetPoint Medical, and Stimwave LLC, among others.
Key Questions Answered in this Report:
- What are the different types of bioelectric medicine available in the market and what are the benefits offered by them?
- What are the major drivers, challenges, and opportunities in the global bioelectric medicine market?
- What are the key development strategies implemented by the key players to stand out in this market?
- What are the leading companies dominating the global bioelectric medicine market?
- How many types of bioelectric medicine are available in the market, and which are the companies offering them?
- Based on product type, which bioelectric medicine is anticipated to witness a massive rise in demand in the forecast period?
- What are the perceptions of the investors about the global bioelectric medicine market?
- What are the regulations pertaining to the global bioelectric medicine market? What are the initiatives implemented by different government bodies regulating the development and commercialization of bioelectric medicine?
- What was the market value in 2018 of the leading segments and sub-segments of the global bioelectric medicine market?
- How is each segment of the global bioelectric medicine market expected to grow during the forecast period, and what is the revenue expected to be generated by each of the segments by the end of 2025?
- How is the industry anticipated to evolve during the forecast period 2019-2025?
- Which region is expected to contribute to the highest sales of the global bioelectric medicine market during the forecast period?
- What are the leading trends and consumer preferences witnessed in global bioelectric medicine markets?
The global bioelectric medicine industry analysis by BIS Research projects the market to grow at a significant CAGR of 6.41% during the forecast period, 2019-2025. The bioelectric medicine market generated $18,636.4 million revenue in 2018.
The bioelectric medicine growth has been primarily attributed to the major drivers such as growing geriatric population leads to surge in exigency of bioelectric medicine, increasing burden of diseases inciting the use of bioelectric medicine, growing investments and funds for the development of novel therapeutics and electroceuticals, limited success rate of drugs targeting specific disease, increasing amount of adverse drug reaction, and upsurge in awareness level. The market is expected to grow at a significant growth rate due to the opportunities that lie within its domain, which include growth in emerging countries and technological advancement in bioelectric medicine. However, there are significant challenges which are restraining the market growth. These challenges include product recall, exorbitant cost of electroceuticals, increased regulatory scrutiny, and complications and side effects associated with the bioelectric medicine devices.
Expert Quote
“The pacemaker represents the biggest opportunity in the bioelectric medicine market, as the demand of pacemaker and awareness of about the pacemakers are higher compare to other bioelectric medicine products. The upsurge prevalence of cardiovascular diseases and growing geriatric population has made it the largest sources of bioelectric medicine for the treatment of cardiovascular disorders.”
Scope of the Market Intelligence on Bioelectric Medicine Market
The bioelectric medicine market research provides a holistic view of the market in terms of various factors influencing it, regulatory reforms, and technological advancements. The scope of this report is centered upon detailed study of the products, associated with the market. In addition, the study also includes exhaustive information on the market needs, details on the new products, competitive landscape, market share of leading players, growth potential of each underlying sub-segment, and company, as well as other vital information with respect to the global bioelectric medicine market.
Market Segmentation
The bioelectric medicine market segmentation (on the basis of product type) is further segmented into implantable and non-implantable.
On the basis of implantable bioelectric medicine, the bioelectric medicine market is segmented into pacemaker, ICDs, spinal cord stimulation devices, cochlear implant, deep brain stimulation device, vagus nerve stimulation device, and others.
Key Companies in the Bioelectric Medicine Industry
The key manufacturers that have been contributing significantly to the bioelectric medicine market include Abbott Laboratories, Boston Scientific Corporation, Cochlear Limited, electroCore, Inc., Inspire Medical Systems, Inc., LivaNova PLC, Medtronic Plc, Nevro Corp., Nuvectra Corporation, NeuroMetrix, Inc., OMRON CORPORATION, PIXIUM VISION, Second Sight Medical Products, Inc., BIOTRONIK SE & Co. KG, MED-EL, SetPoint Medical, and Stimwave LLC, among others.
EXECUTIVE SUMMARY
1 PRODUCT DEFINITION
2 SCOPE OF WORK
2.1 Overview: Report Scope
2.2 Segmentation of the Global Bioelectric Medicine Market
2.3 Assumptions and Limitations
2.4 Key Questions Answered in the Report:
2.5 Base Year and Forecast Period
3 RESEARCH METHODOLOGY
3.1 Overview: Research Methodology
4 INDUSTRY ANALYSIS
4.1 Regulatory Scenario
4.1.1 Legal Requirements and Regulations
4.1.1.1 Regulations in the U.S.
4.1.1.2 Regulations in Europe
4.1.1.3 Regulations in Other Countries
4.2 Patent Analysis
4.3 Product Pipeline
5 COMPETITIVE LANDSCAPE
5.1 Overview
5.2 Key Strategies and Development (2016-2019)
5.2.1 Product Launches, Approvals, and Clearances
5.2.2 Joint Venture, Agreement, Collaborations, and Partnerships
5.2.3 Mergers and Acquisitions
5.2.4 Business Expansion
5.3 Market Share Analysis of Spinal Cord Stimulation Devices in the Global Bioelectric Medicine Market
5.4 Market Share Analysis of Cochlear Implant in the Global Bioelectric Medicine Market
5.5 Market Share Analysis of Pacemaker and ICD in the Global Bioelectric Medicine Market
5.6 Growth Share Analysis
6 EVOLUTION OF BIOELECTRIC MEDICINE
6.1 Evolution of the Pacemaker
6.2 Enabling Technologies Evolving Pacemaker and ICD
6.3 Evolution of the Neurostimulation Therapy
6.4 Enabling Technologies Evolving Neurostimulation Therapies
7 GLOBAL BIOELECTRIC MEDICINE MARKET, 2018-2025
7.1 Assumptions and Limitations
7.2 Global Market Scenario
7.3 Market Dynamics
7.3.1 Overview
7.3.2 Impact Analysis
7.3.3 Market Drivers
7.3.3.1 Growing Geriatric Population Leads to Surge in Exigency of Bioelectric Medicine
7.3.3.2 Increasing Burden of Disease Inciting the Use of Bioelectric Medicine
7.3.3.2.1 Increasing Prevalence of Neurological Disorders
7.3.3.2.2 Increasing Prevalence of Hearing Loss
7.3.3.2.3 Increasing Prevalence of Cardiovascular Disorders
7.3.3.2.4 Increasing Burden of Blindness
7.3.3.3 Growing Investments and Funds for the Development of Novel Therapies and Electroceuticals
7.3.3.4 Limited Success Rate of Drugs Targeting Specific Disease
7.3.3.5 Increasing Amount of Adverse Drug Reaction
7.3.3.6 Upsurge in Awareness Level
7.3.4 Market Restraints
7.3.4.1 Product Recall
7.3.4.2 Exorbitant Cost of Electroceuticals
7.3.4.3 Increased Regulatory Scrutiny
7.3.4.4 Complications and Side-Effects Associated with the Bioelectric Medicine Devices
7.3.5 Market Opportunities
7.3.5.1 Growth in Emerging Countries
7.3.5.2 Technological Advancement in Bioelectric Medicine
7.3.5.2.1 Development of Closed Loop Neuromodulation
7.3.5.2.2 Evolution of Biomarker-Based Therapeutics Enabling Early Diagnostics of Neurological Disorders
7.3.5.2.3 Technological Advancement in Pacemakers
7.3.5.2.4 Technological Advancement in ICDs
8 GLOBAL BIOELECTRIC MEDICINE MARKET BY PRODUCT TYPE, 2018-2025
8.1 Overview
8.2 Competitive Benchmarking
8.3 Implantable Bioelectric Medicine
8.3.1 Cardiac Pacemaker
8.3.2 Implantable Cardioverter Defibrillators (ICD)
8.3.3 Spinal Cord Stimulation Device
8.3.4 Cochlear Implants
8.3.5 Deep Brain Stimulation Device
8.3.6 Vagus Nerve Stimulation Device
8.3.7 Others
8.4 Non-Implantable Bioelectric Medicine
9 GLOBAL BIOELECTRIC MEDICINE MARKET (BY REGION)
9.1 Overview
9.2 North America
9.2.1 North America: Bioelectric Medicine Market by Product
9.2.1.1 North America: Implantable Bioelectric Medicine Market by Product
9.2.2 North America: Bioelectric Medicine Market by Country
9.2.2.1 U.S.
9.2.2.1.1 U.S.: Bioelectric Medicine Market by Product
9.2.2.1.1.1 U.S.: Implantable Bioelectric Medicine Market by Product
9.2.2.2 Canada
9.2.2.2.1 Canada: Bioelectric Medicine Market by Product
9.2.2.2.1.1 Canada: Implantable Bioelectric Medicine Market by Product
9.3 Europe
9.3.1 Europe: Bioelectric Medicine Market by Product
9.3.1.1 Europe: Implantable Bioelectric Medicine Market by Product
9.3.2 Europe: Bioelectric Medicine Market by Country
9.3.2.1 Germany
9.3.2.1.1 Germany: Bioelectric Medicine Market by Product Type
9.3.2.1.1.1 Germany: Implantable Bioelectric Medicine Market by Product
9.3.2.2 U.K.
9.3.2.2.1 U.K.: Bioelectric Medicine Market by Product
9.3.2.2.1.1 U.K.: Implantable Bioelectric Medicine Market by Product
9.3.2.3 France
9.3.2.3.1 France: Bioelectric Medicine Market by Product
9.3.2.3.1.1 France: Implantable Bioelectric Medicine Market by Product
9.3.2.4 Italy
9.3.2.4.1 Italy: Bioelectric Medicine Market by Product
9.3.2.4.1.1 Italy: Implantable Bioelectric Medicine Market by Product
9.3.2.5 Spain
9.3.2.5.1 Spain: Bioelectric Medicine Market by Product
9.3.2.5.1.1 Spain: Implantable Bioelectric Medicine Market by Product
9.3.2.6 Rest-of-Europe
9.3.2.6.1 Rest-of-Europe: Bioelectric Medicine Market by Product
9.3.2.6.1.1 Rest-of-Europe: Implantable Bioelectric Medicine Market by Product
9.4 Asia-Pacific
9.4.1 Asia-Pacific: Bioelectric Medicine Market by Product
9.4.1.1 Asia-Pacific: Implantable Bioelectric Medicine Market by Product
9.4.2 Asia-Pacific: Bioelectric Medicine Market by Country
9.4.2.1 Japan
9.4.2.1.1 Japan: Bioelectric Medicine Market by Product
9.4.2.1.1.1 Japan: Implantable Bioelectric Medicine Market by Product
9.4.2.2 China
9.4.2.2.1 China: Bioelectric Medicine Market by Product
9.4.2.2.1.1 China: Implantable Bioelectric Medicine Market by Product
9.4.2.3 India
9.4.2.3.1 India: Bioelectric Medicine Market by Product
9.4.2.3.1.1 India: Implantable Bioelectric Medicine Market by Product
9.4.2.4 South Korea
9.4.2.4.1 South Korea: Bioelectric Medicine Market by Product
9.4.2.4.1.1 South Korea: Implantable Bioelectric Medicine Market by Product
9.4.2.5 Rest-of-Asia-Pacific
9.4.2.5.1 Rest-of-Asia-Pacific: Bioelectric Medicine Market by Product
9.4.2.5.1.1 Rest-of-Asia-Pacific: Implantable Bioelectric Medicine Market by Product
9.5 Latin America
9.5.1 Latin America: Bioelectric Medicine Market by Product
9.5.1.1 Latin America: Implantable Bioelectric Medicine Market by Product
9.5.2 Latin America: Bioelectric Medicine Market by Country
9.5.2.1 Brazil
9.5.2.1.1 Brazil: Bioelectric Medicine Market by Product
9.5.2.1.1.1 Brazil: Implantable Bioelectric Medicine Market by Product
9.5.2.2 Mexico
9.5.2.2.1 Mexico: Bioelectric Medicine Market by Product
9.5.2.2.1.1 Mexico: Implantable Bioelectric Medicine Market by Product
9.5.2.3 Rest-of-Latin America
9.5.2.3.1 Rest-of-Latin America: Bioelectric Medicine Market by Product
9.5.2.3.1.1 Rest-of-Latin America: Implantable Bioelectric Medicine Market by Product
9.6 Middle East and Africa
9.6.1 Middle East and Africa: Bioelectric Medicine Market by Product
9.6.1.1 Middle East and Africa: Implantable Bioelectric Medicine Market by Product
10 COMPANY PROFILE
10.1 Overview
10.2 Abbott Laboratories
10.2.1 Company Overview
10.2.2 Financials
10.2.3 Role of Abbott Laboratories in the Bioelectric Medicines Market
10.2.4 SWOT Analysis
10.3 Boston Scientific Corporation
10.3.1 Company Overview
10.3.2 Financials
10.3.3 Role of Boston Scientific Corporation in the Bioelectric Medicines Market
10.3.4 SWOT Analysis
10.4 BIOTRONIK SE & Co. KG
10.4.1 Company Overview
10.4.2 Role of BIOTRONIK SE & Co. KG in the Bioelectric Medicines Market
10.4.3 SWOT Analysis
10.5 Cochlear Limited
10.5.1 Company Overview
10.5.2 Financials
10.5.3 Role of Cochlear Limited in the Bioelectric Medicines Market
10.5.4 SWOT Analysis
10.6 electroCore, Inc.
10.6.1 Company Overview
10.6.2 Financials
10.6.3 Role of electroCore, Inc. in the Bioelectric Medicines Market
10.6.4 SWOT Analysis
10.7 Inspire Medical Systems, Inc.
10.7.1 Company Overview
10.7.2 Financials
10.7.3 Role of Inspire Medical Systems, Inc. in the Bioelectric Medicines Market
10.7.4 SWOT Analysis
10.8 LivaNova Plc
10.8.1 Company Overview
10.8.2 Financials
10.8.3 Role of LivaNova, Plc in the Bioelectric Medicines Market
10.8.4 SWOT Analysis
10.9 Medtronic Plc
10.9.1 Company Overview
10.9.2 Financials
10.9.3 Role of Medtronic Plc in the Bioelectric Medicine Market
10.9.4 SWOT Analysis
10.10 MED-EL
10.10.1 Company Overview
10.10.2 Role of MED-EL in the Bioelectric Medicines Market
10.10.3 SWOT Analysis
10.11 Nevro Corp.
10.11.1 Company Overview
10.11.2 Financials
10.11.3 Role of Nevro Corp. in the Bioelectric Medicines Market
10.11.4 SWOT Analysis
10.12 Nuvectra Corporation
10.12.1 Company Overview
10.12.2 Financials
10.12.3 Role of Nuvectra Corporation in the Bioelectric Medicines Market
10.12.4 SWOT Analysis
10.13 NeuroMetrix, Inc
10.13.1 Company Overview
10.13.2 Financials
10.13.3 Role of NeuroMetrix, Inc. in the Bioelectric Medicines Market
10.13.4 SWOT Analysis
10.14 OMRON CORPORATION
10.14.1 Company Overview
10.14.2 Financials
10.14.3 Role of Omron Corporation in the Global Bioelectric Medicine Market
10.14.4 SWOT Analysis
10.15 PIXIUM VISION
10.15.1 Company Overview
10.15.2 Role of PIXIUM VISION in the Bioelectric Medicines Market
10.15.3 SWOT Analysis
10.16 Second Sight Medical Products, Inc.
10.16.1 Company Overview
10.16.2 Financials
10.16.3 Role of Second Sight Medical Products, Inc. in the Bioelectric Medicines Market
10.16.4 SWOT Analysis
10.17 SetPoint Medical
10.17.1 Company Overview
10.17.2 Role of SetPoint Medical in the Bioelectric Medicines Market
10.17.3 SWOT Analysis
10.18 Stimwave LLC
10.18.1 Company Overview
10.18.2 Role of Stimwave LLC in the Bioelectric Medicines Market
10.18.3 SWOT Analysis
1 PRODUCT DEFINITION
2 SCOPE OF WORK
2.1 Overview: Report Scope
2.2 Segmentation of the Global Bioelectric Medicine Market
2.3 Assumptions and Limitations
2.4 Key Questions Answered in the Report:
2.5 Base Year and Forecast Period
3 RESEARCH METHODOLOGY
3.1 Overview: Research Methodology
4 INDUSTRY ANALYSIS
4.1 Regulatory Scenario
4.1.1 Legal Requirements and Regulations
4.1.1.1 Regulations in the U.S.
4.1.1.2 Regulations in Europe
4.1.1.3 Regulations in Other Countries
4.2 Patent Analysis
4.3 Product Pipeline
5 COMPETITIVE LANDSCAPE
5.1 Overview
5.2 Key Strategies and Development (2016-2019)
5.2.1 Product Launches, Approvals, and Clearances
5.2.2 Joint Venture, Agreement, Collaborations, and Partnerships
5.2.3 Mergers and Acquisitions
5.2.4 Business Expansion
5.3 Market Share Analysis of Spinal Cord Stimulation Devices in the Global Bioelectric Medicine Market
5.4 Market Share Analysis of Cochlear Implant in the Global Bioelectric Medicine Market
5.5 Market Share Analysis of Pacemaker and ICD in the Global Bioelectric Medicine Market
5.6 Growth Share Analysis
6 EVOLUTION OF BIOELECTRIC MEDICINE
6.1 Evolution of the Pacemaker
6.2 Enabling Technologies Evolving Pacemaker and ICD
6.3 Evolution of the Neurostimulation Therapy
6.4 Enabling Technologies Evolving Neurostimulation Therapies
7 GLOBAL BIOELECTRIC MEDICINE MARKET, 2018-2025
7.1 Assumptions and Limitations
7.2 Global Market Scenario
7.3 Market Dynamics
7.3.1 Overview
7.3.2 Impact Analysis
7.3.3 Market Drivers
7.3.3.1 Growing Geriatric Population Leads to Surge in Exigency of Bioelectric Medicine
7.3.3.2 Increasing Burden of Disease Inciting the Use of Bioelectric Medicine
7.3.3.2.1 Increasing Prevalence of Neurological Disorders
7.3.3.2.2 Increasing Prevalence of Hearing Loss
7.3.3.2.3 Increasing Prevalence of Cardiovascular Disorders
7.3.3.2.4 Increasing Burden of Blindness
7.3.3.3 Growing Investments and Funds for the Development of Novel Therapies and Electroceuticals
7.3.3.4 Limited Success Rate of Drugs Targeting Specific Disease
7.3.3.5 Increasing Amount of Adverse Drug Reaction
7.3.3.6 Upsurge in Awareness Level
7.3.4 Market Restraints
7.3.4.1 Product Recall
7.3.4.2 Exorbitant Cost of Electroceuticals
7.3.4.3 Increased Regulatory Scrutiny
7.3.4.4 Complications and Side-Effects Associated with the Bioelectric Medicine Devices
7.3.5 Market Opportunities
7.3.5.1 Growth in Emerging Countries
7.3.5.2 Technological Advancement in Bioelectric Medicine
7.3.5.2.1 Development of Closed Loop Neuromodulation
7.3.5.2.2 Evolution of Biomarker-Based Therapeutics Enabling Early Diagnostics of Neurological Disorders
7.3.5.2.3 Technological Advancement in Pacemakers
7.3.5.2.4 Technological Advancement in ICDs
8 GLOBAL BIOELECTRIC MEDICINE MARKET BY PRODUCT TYPE, 2018-2025
8.1 Overview
8.2 Competitive Benchmarking
8.3 Implantable Bioelectric Medicine
8.3.1 Cardiac Pacemaker
8.3.2 Implantable Cardioverter Defibrillators (ICD)
8.3.3 Spinal Cord Stimulation Device
8.3.4 Cochlear Implants
8.3.5 Deep Brain Stimulation Device
8.3.6 Vagus Nerve Stimulation Device
8.3.7 Others
8.4 Non-Implantable Bioelectric Medicine
9 GLOBAL BIOELECTRIC MEDICINE MARKET (BY REGION)
9.1 Overview
9.2 North America
9.2.1 North America: Bioelectric Medicine Market by Product
9.2.1.1 North America: Implantable Bioelectric Medicine Market by Product
9.2.2 North America: Bioelectric Medicine Market by Country
9.2.2.1 U.S.
9.2.2.1.1 U.S.: Bioelectric Medicine Market by Product
9.2.2.1.1.1 U.S.: Implantable Bioelectric Medicine Market by Product
9.2.2.2 Canada
9.2.2.2.1 Canada: Bioelectric Medicine Market by Product
9.2.2.2.1.1 Canada: Implantable Bioelectric Medicine Market by Product
9.3 Europe
9.3.1 Europe: Bioelectric Medicine Market by Product
9.3.1.1 Europe: Implantable Bioelectric Medicine Market by Product
9.3.2 Europe: Bioelectric Medicine Market by Country
9.3.2.1 Germany
9.3.2.1.1 Germany: Bioelectric Medicine Market by Product Type
9.3.2.1.1.1 Germany: Implantable Bioelectric Medicine Market by Product
9.3.2.2 U.K.
9.3.2.2.1 U.K.: Bioelectric Medicine Market by Product
9.3.2.2.1.1 U.K.: Implantable Bioelectric Medicine Market by Product
9.3.2.3 France
9.3.2.3.1 France: Bioelectric Medicine Market by Product
9.3.2.3.1.1 France: Implantable Bioelectric Medicine Market by Product
9.3.2.4 Italy
9.3.2.4.1 Italy: Bioelectric Medicine Market by Product
9.3.2.4.1.1 Italy: Implantable Bioelectric Medicine Market by Product
9.3.2.5 Spain
9.3.2.5.1 Spain: Bioelectric Medicine Market by Product
9.3.2.5.1.1 Spain: Implantable Bioelectric Medicine Market by Product
9.3.2.6 Rest-of-Europe
9.3.2.6.1 Rest-of-Europe: Bioelectric Medicine Market by Product
9.3.2.6.1.1 Rest-of-Europe: Implantable Bioelectric Medicine Market by Product
9.4 Asia-Pacific
9.4.1 Asia-Pacific: Bioelectric Medicine Market by Product
9.4.1.1 Asia-Pacific: Implantable Bioelectric Medicine Market by Product
9.4.2 Asia-Pacific: Bioelectric Medicine Market by Country
9.4.2.1 Japan
9.4.2.1.1 Japan: Bioelectric Medicine Market by Product
9.4.2.1.1.1 Japan: Implantable Bioelectric Medicine Market by Product
9.4.2.2 China
9.4.2.2.1 China: Bioelectric Medicine Market by Product
9.4.2.2.1.1 China: Implantable Bioelectric Medicine Market by Product
9.4.2.3 India
9.4.2.3.1 India: Bioelectric Medicine Market by Product
9.4.2.3.1.1 India: Implantable Bioelectric Medicine Market by Product
9.4.2.4 South Korea
9.4.2.4.1 South Korea: Bioelectric Medicine Market by Product
9.4.2.4.1.1 South Korea: Implantable Bioelectric Medicine Market by Product
9.4.2.5 Rest-of-Asia-Pacific
9.4.2.5.1 Rest-of-Asia-Pacific: Bioelectric Medicine Market by Product
9.4.2.5.1.1 Rest-of-Asia-Pacific: Implantable Bioelectric Medicine Market by Product
9.5 Latin America
9.5.1 Latin America: Bioelectric Medicine Market by Product
9.5.1.1 Latin America: Implantable Bioelectric Medicine Market by Product
9.5.2 Latin America: Bioelectric Medicine Market by Country
9.5.2.1 Brazil
9.5.2.1.1 Brazil: Bioelectric Medicine Market by Product
9.5.2.1.1.1 Brazil: Implantable Bioelectric Medicine Market by Product
9.5.2.2 Mexico
9.5.2.2.1 Mexico: Bioelectric Medicine Market by Product
9.5.2.2.1.1 Mexico: Implantable Bioelectric Medicine Market by Product
9.5.2.3 Rest-of-Latin America
9.5.2.3.1 Rest-of-Latin America: Bioelectric Medicine Market by Product
9.5.2.3.1.1 Rest-of-Latin America: Implantable Bioelectric Medicine Market by Product
9.6 Middle East and Africa
9.6.1 Middle East and Africa: Bioelectric Medicine Market by Product
9.6.1.1 Middle East and Africa: Implantable Bioelectric Medicine Market by Product
10 COMPANY PROFILE
10.1 Overview
10.2 Abbott Laboratories
10.2.1 Company Overview
10.2.2 Financials
10.2.3 Role of Abbott Laboratories in the Bioelectric Medicines Market
10.2.4 SWOT Analysis
10.3 Boston Scientific Corporation
10.3.1 Company Overview
10.3.2 Financials
10.3.3 Role of Boston Scientific Corporation in the Bioelectric Medicines Market
10.3.4 SWOT Analysis
10.4 BIOTRONIK SE & Co. KG
10.4.1 Company Overview
10.4.2 Role of BIOTRONIK SE & Co. KG in the Bioelectric Medicines Market
10.4.3 SWOT Analysis
10.5 Cochlear Limited
10.5.1 Company Overview
10.5.2 Financials
10.5.3 Role of Cochlear Limited in the Bioelectric Medicines Market
10.5.4 SWOT Analysis
10.6 electroCore, Inc.
10.6.1 Company Overview
10.6.2 Financials
10.6.3 Role of electroCore, Inc. in the Bioelectric Medicines Market
10.6.4 SWOT Analysis
10.7 Inspire Medical Systems, Inc.
10.7.1 Company Overview
10.7.2 Financials
10.7.3 Role of Inspire Medical Systems, Inc. in the Bioelectric Medicines Market
10.7.4 SWOT Analysis
10.8 LivaNova Plc
10.8.1 Company Overview
10.8.2 Financials
10.8.3 Role of LivaNova, Plc in the Bioelectric Medicines Market
10.8.4 SWOT Analysis
10.9 Medtronic Plc
10.9.1 Company Overview
10.9.2 Financials
10.9.3 Role of Medtronic Plc in the Bioelectric Medicine Market
10.9.4 SWOT Analysis
10.10 MED-EL
10.10.1 Company Overview
10.10.2 Role of MED-EL in the Bioelectric Medicines Market
10.10.3 SWOT Analysis
10.11 Nevro Corp.
10.11.1 Company Overview
10.11.2 Financials
10.11.3 Role of Nevro Corp. in the Bioelectric Medicines Market
10.11.4 SWOT Analysis
10.12 Nuvectra Corporation
10.12.1 Company Overview
10.12.2 Financials
10.12.3 Role of Nuvectra Corporation in the Bioelectric Medicines Market
10.12.4 SWOT Analysis
10.13 NeuroMetrix, Inc
10.13.1 Company Overview
10.13.2 Financials
10.13.3 Role of NeuroMetrix, Inc. in the Bioelectric Medicines Market
10.13.4 SWOT Analysis
10.14 OMRON CORPORATION
10.14.1 Company Overview
10.14.2 Financials
10.14.3 Role of Omron Corporation in the Global Bioelectric Medicine Market
10.14.4 SWOT Analysis
10.15 PIXIUM VISION
10.15.1 Company Overview
10.15.2 Role of PIXIUM VISION in the Bioelectric Medicines Market
10.15.3 SWOT Analysis
10.16 Second Sight Medical Products, Inc.
10.16.1 Company Overview
10.16.2 Financials
10.16.3 Role of Second Sight Medical Products, Inc. in the Bioelectric Medicines Market
10.16.4 SWOT Analysis
10.17 SetPoint Medical
10.17.1 Company Overview
10.17.2 Role of SetPoint Medical in the Bioelectric Medicines Market
10.17.3 SWOT Analysis
10.18 Stimwave LLC
10.18.1 Company Overview
10.18.2 Role of Stimwave LLC in the Bioelectric Medicines Market
10.18.3 SWOT Analysis
LIST OF TABLES
Table 4.1: Regulatory Authorities/ Associations/ Consortium of the Global Bioelectric Medicine Market
Table 4.2: Some of the Product Pipeline for Bioelectric Medicine Market
Table 7.1: Leading Cause of Disability in 1990 and 2017
Table 7.2: Global Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
Table 7.3: Projected Hearing Loss Population Across the Globe
Table 7.4: Prevalence of Hearing Loss Across the World
Table 7.5: Bioelectric Medicine Growing Investment
Table 7.6: Some of the Funding in Bioelectric Medicine
Table 7.7: Some of the Product Recall of the Bioelectric Medicine
Table 8.1: Competitive Benchmarking by Product
Table 8.2: Some of the Clinical Studies Undergoing for Cardiac Pacemaker
Table 8.3: Pacemaker in the Global Bioelectric Medicine Market (by Region) 2018-2025, $Million
Table 8.4: Some of the Clinical Studies Undergoing for ICD
Table 8.5: ICD in the Global Bioelectric Medicine Market (by Region) 2018-2025, $Million
Table 8.6: Some of the Clinical Studies Undergoing for Spinal Cord Stimulation Device
Table 8.7: Specification of Different Spinal Cord Stimulation Device Offered by Different Companies
Table 8.8: Spinal Cord Stimulation Device in the Global Bioelectric Medicine Market (by Region) 2018-2025, $Million
Table 8.9: Some of the Clinical Studies Undergoing for Cochlear Implant
Table 8.10: Cochlear Implant in the Global Bioelectric Medicine Market (by Region) 2018-2025, $Million
Table 8.11: Some of the Clinical Studies Undergoing for Deep Brain Stimulation
Table 8.12: Deep Brain Stimulation in the Global Bioelectric Medicine Market (by Region) 2018-2025, $Million
Table 8.13: Some of the Clinical Studies Undergoing for Vagus Nerve Stimulation
Table 8.14: Vagus Nerve Stimulation in the Global Bioelectric Medicine Market (by Region) 2018-2025, $Million
Table 8.15: Others in the Global Bioelectric Medicine Market (by Region) 2018-2025, $Million
Table 8.16: Non-Implantable in the Global Bioelectric Medicine Market (by Region) 2018-2025, $Million
Table 9.1: North America Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
Table 9.2: Cardiac Procedure Volume in the U.S., 2014
Table 9.3: U.S. Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
Table 9.4: Canada Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
Table 9.5: Implantation of Pacemaker and ICDs
Table 9.6: Europe Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
Table 9.7: Germany Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
Table 9.8: U.K. Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
Table 9.9: France Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
Table 9.10: Italy Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
Table 9.11: Spain Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
Table 9.12: Asia Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
Table 9.13: Units of Pacemaker and ICDs in Asia-Pacific Region
Table 9.14: Japan Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
Table 9.15: China Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
Table 9.16: India Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
Table 9.17: South Korea Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
Table 9.18: Latin America and Caribbean Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
Table 9.19: Brazil Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
Table 9.20: Mexico Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
Table 9.21: Argentina Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
Table 9.22: North Africa and Middle East Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
Table 9.23: Pacemaker Implantation Rate Per Million Population in Africa from 2011-2016
Table 4.1: Regulatory Authorities/ Associations/ Consortium of the Global Bioelectric Medicine Market
Table 4.2: Some of the Product Pipeline for Bioelectric Medicine Market
Table 7.1: Leading Cause of Disability in 1990 and 2017
Table 7.2: Global Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
Table 7.3: Projected Hearing Loss Population Across the Globe
Table 7.4: Prevalence of Hearing Loss Across the World
Table 7.5: Bioelectric Medicine Growing Investment
Table 7.6: Some of the Funding in Bioelectric Medicine
Table 7.7: Some of the Product Recall of the Bioelectric Medicine
Table 8.1: Competitive Benchmarking by Product
Table 8.2: Some of the Clinical Studies Undergoing for Cardiac Pacemaker
Table 8.3: Pacemaker in the Global Bioelectric Medicine Market (by Region) 2018-2025, $Million
Table 8.4: Some of the Clinical Studies Undergoing for ICD
Table 8.5: ICD in the Global Bioelectric Medicine Market (by Region) 2018-2025, $Million
Table 8.6: Some of the Clinical Studies Undergoing for Spinal Cord Stimulation Device
Table 8.7: Specification of Different Spinal Cord Stimulation Device Offered by Different Companies
Table 8.8: Spinal Cord Stimulation Device in the Global Bioelectric Medicine Market (by Region) 2018-2025, $Million
Table 8.9: Some of the Clinical Studies Undergoing for Cochlear Implant
Table 8.10: Cochlear Implant in the Global Bioelectric Medicine Market (by Region) 2018-2025, $Million
Table 8.11: Some of the Clinical Studies Undergoing for Deep Brain Stimulation
Table 8.12: Deep Brain Stimulation in the Global Bioelectric Medicine Market (by Region) 2018-2025, $Million
Table 8.13: Some of the Clinical Studies Undergoing for Vagus Nerve Stimulation
Table 8.14: Vagus Nerve Stimulation in the Global Bioelectric Medicine Market (by Region) 2018-2025, $Million
Table 8.15: Others in the Global Bioelectric Medicine Market (by Region) 2018-2025, $Million
Table 8.16: Non-Implantable in the Global Bioelectric Medicine Market (by Region) 2018-2025, $Million
Table 9.1: North America Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
Table 9.2: Cardiac Procedure Volume in the U.S., 2014
Table 9.3: U.S. Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
Table 9.4: Canada Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
Table 9.5: Implantation of Pacemaker and ICDs
Table 9.6: Europe Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
Table 9.7: Germany Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
Table 9.8: U.K. Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
Table 9.9: France Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
Table 9.10: Italy Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
Table 9.11: Spain Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
Table 9.12: Asia Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
Table 9.13: Units of Pacemaker and ICDs in Asia-Pacific Region
Table 9.14: Japan Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
Table 9.15: China Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
Table 9.16: India Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
Table 9.17: South Korea Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
Table 9.18: Latin America and Caribbean Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
Table 9.19: Brazil Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
Table 9.20: Mexico Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
Table 9.21: Argentina Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
Table 9.22: North Africa and Middle East Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
Table 9.23: Pacemaker Implantation Rate Per Million Population in Africa from 2011-2016
LIST OF FIGURES
Figure 1: Global Bioelectric Medicine Market Snapshot
Figure 2: Market Drivers and Market Restraints
Figure 3: Competitive Scenario of Spinal Cord Stimulation Device in the Global Bioelectric Medicine Market
Figure 4: Global Bioelectric Medicine Market, 2018-2025
Figure 5: Growth Share Matrix of Products, 2018
Figure 1.1: Examples of Diseases that are Potential Target for Bioelectric Medicine
Figure 2.1: Global Bioelectric Medicine: Market Segmentation
Figure 3.1: Bioelectric Medicine Market Research Methodology
Figure 3.2: Primary Research
Figure 3.3: Secondary Research
Figure 3.4: Data Triangulation
Figure 3.5: Top-Down Approach (Segment-Wise Analysis)
Figure 3.6: Bottom-Up Approach (Segment-Wise Analysis)
Figure 3.7: Assumptions and Limitations
Figure 3.8: Considered Factors for Data Prediction and Modeling
Figure 4.1: Share of Patent by Ownership, January 2016- July 2019
Figure 5.1: Competitive Landscape
Figure 5.2: Share of Key Developments and Strategies- January 2016- July 2019
Figure 5.3: Product Launches, Approvals, and Clearances (by Company), January 2016 -July 2019
Figure 5.4: Agreements, Collaborations, Joint Ventures, and Partnership (by Company). January 2016-July 2019
Figure 5.5: Mergers and Acquisitions (by Company), January 2016–July 2019
Figure 5.6: Business Expansion (by Company), January 2016- July 2019
Figure 5.7: Market Share Analysis (by Company), for Spinal Cord Stimulation Devices in the Bioelectric Medicine Market, 2018
Figure 5.8: Market Share Analysis (by Company), for Cochlear Implant in the Global Bioelectric Medicine Market, 2018
Figure 5.9: Market Share Analysis (by Company), for Pacemaker and ICD in the Global Bioelectric Medicine Market, 2018
Figure 5.10: Growth Share Matrix for Global Implantable Bioelectric Medicine Market, by Products, 2018
Figure 6.1: Evolution of Pacemaker and ICD
Figure 6.2: FDA Approval Indications by Various Vendor Products
Figure 7.1: Segmentation of Bioelectric Medicine Market
Figure 7.2: Global Bioelectric Medicine Market, 2018-2025
Figure 7.3: Drivers, Restraints, and Opportunities of the Global Bioelectric Medicine Market
Figure 7.4: Impact Analysis
Figure 7.5: Geriatric Population (60 years and above) Worldwide in Different Regions, 2000, 2015, 2030, 2050
Figure 7.6: U.S. Annual Alzheimer’s Death Rate (per 100,000 People) by Year
Figure 8.1: Segmentation of Bioelectric Medicine Market, by Product Type
Figure 8.2: Global Bioelectric Medicine Market, by Product Type, Market Share 2018
Figure 8.3: Implantable Bioelectric Medicine in the Global Bioelectric Medicine Market, 2018 and 2025
Figure 8.4: Mechanism of Action Pacemaker
Figure 8.5: Pacemaker in the Global Bioelectric Medicine Market, 2018-2025
Figure 8.6: Mechanism Action of ICD
Figure 8.7: ICD in the Global Bioelectric Medicine Market, 2018-2025
Figure 8.8: Mechanism Action of Spinal Cord Stimulation Device
Figure 8.9: Spinal Cord Stimulation Device in the Global Bioelectric Medicine Market, 2018-2025
Figure 8.10: Mechanism of Action of Cochlear Implants
Figure 8.11: Cochlear Implant in the Global Bioelectric Medicine Market, 2018-2025
Figure 8.12: Deep Brain Stimulation Device in the Global Bioelectric Medicine Market. 2018-2025
Figure 8.13: Vagus Nerve Stimulation Device in the Global Bioelectric Medicine Market. 2018-2025
Figure 8.14: Others in the Global Bioelectric Medicine Market. 2018-2025
Figure 8.15: Non-Implantable in the Global Bioelectric Medicine Market. 2018-2025
Figure 9.1: Global Bioelectric Medicine Market Scenario, 2018
Figure 9.2: North America: Bioelectric Medicine Market, 2018-2025
Figure 9.3: North America: Market Dynamics
Figure 9.4: North America: Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.5: North America: Implantable Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.6: North America: Bioelectric Medicine Market (by Country), 2018 and 2025
Figure 9.7: Alzheimer’s Dementia in Different Age Groups in the U.S., 2018
Figure 9.8: U.S.: Bioelectric Medicine Market, 2018-2025
Figure 9.9: U.S.: Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.10: U.S.: Implantable Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.11: Canada: Bioelectric Medicine Market, 2018-2025
Figure 9.12: Canada: Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.13: Canada: Implantable Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.14: Number of People with Parkinson’s Disease in Different European Countries
Figure 9.15: Europe: Bioelectric Medicine Market, 2018-2025
Figure 9.16: Europe: Market Dynamics
Figure 9.17: Europe: Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.18: Europe: Implantable Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.19: Europe: Bioelectric Medicine Market (by Country), 2018 and 2025
Figure 9.20: Germany: Bioelectric Medicine Market, 2018-2025
Figure 9.21: Germany: Bioelectric Medicine Market (by Product Type), 2018-2025
Figure 9.22: Germany: Implantable Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.23: U.K.: Bioelectric Medicine Market, 2018-2025
Figure 9.24: U.K.: Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.25: U.K.: Implantable Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.26: France: Bioelectric Medicine Market, 2018-2025
Figure 9.27: France: Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.28: France: Implantable Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.29: Italy: Bioelectric Medicine Market, 2018-2025
Figure 9.30: Italy: Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.31: Italy: Implantable Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.32: Spain: Bioelectric Medicine Market, 2018-2025
Figure 9.33: Spain: Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.34: Spain: Implantable Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.35: Rest-of-Europe: Bioelectric Medicine Market, 2018-2025
Figure 9.36: Rest-of-Europe: Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.37: Rest-of-Europe: Implantable Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.38: Asia-Pacific: Bioelectric Medicine Market, 2018-2025
Figure 9.39: Asia-Pacific: Market Dynamics
Figure 9.40: Asia-Pacific: Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.41: Asia-Pacific: Implantable Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.42: Asia-Pacific: Bioelectric Medicine Market (by Country), 2018 and 2025
Figure 9.43: Japan: Bioelectric Medicine Market, 2018-2025
Figure 9.44: Japan: Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.45: Japan: Implantable Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.46: China: Bioelectric Medicine Market, 2018-2025
Figure 9.47: China: Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.48: China: Implantable Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.49: India: Bioelectric Medicine Market, 2018-2025
Figure 9.50: India: Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.51: India: Implantable Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.52: South Korea: Bioelectric Medicine Market, 2018-2025
Figure 9.53: South Korea: Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.54: South Korea: Implantable Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.55: Rest-of-Asia-Pacific: Bioelectric Medicine Market, 2018-2025
Figure 9.56: Rest-of-Asia-Pacific: Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.57: Rest-of-Asia-Pacific: Implantable Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.58: Latin America: Bioelectric Medicine Market, 2018-2025
Figure 9.59: Latin America: Market Dynamics
Figure 9.60: Latin America: Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.61: Latin America: Implantable Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.62: Latin America: Bioelectric Medicine Market (by Country), 2018 and 2025
Figure 9.63: Brazil: Bioelectric Medicine Market, 2018-2025
Figure 9.64: Brazil: Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.65: Brazil: Implantable Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.66: Mexico: Bioelectric Medicine Market, 20182025
Figure 9.67: Mexico: Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.68: Mexico: Implantable Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.69: Rest-of-Latin America: Bioelectric Medicine Market, 2018-2025
Figure 9.70: Rest-of-Latin America: Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.71: Rest-of-Latin America: Implantable Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.72: Middle East and Africa: Bioelectric Medicine Market, 2018-2025
Figure 9.73: Middle East and Africa: Market Dynamics
Figure 9.74: Middle East and Africa: Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.75: Middle East and Africa: Implantable Bioelectric Medicine Market (by Product), 2018-2025
Figure 10.1: Total Number of Companies Profiles
Figure 10.2: Abbott Laboratories: Overall Financials, 2016-2018
Figure 10.3: Abbott Laboratories - Revenue (by Segment), 2016-2018
Figure 10.4: Abbott Laboratories - Revenue (by Region), 2016-2018
Figure 10.5: Abbott Laboratories - Research and Development Expense, 2016-2018
Figure 10.6: Abbott Laboratories: Overall Product Portfolio
Figure 10.7: SWOT Analysis – Abbott Laboratories
Figure 10.8: Boston Scientific Corporation: Overall Financials, 2016-2018
Figure 10.9: Boston Scientific Corporation - Revenue (by Segment), 2016-2018
Figure 10.10: Boston Scientific Corporation - Research and Development Expense, 2016-2018
Figure 10.11: Boston Scientific Corporation: Overall Product Portfolio
Figure 10.12: SWOT Analysis – Boston Scientific Corporation
Figure 10.13: BIOTRONIK SE & Co. KG: Overall Product Portfolio
Figure 10.14: SWOT Analysis – BIOTRONIK SE & Co. KG
Figure 10.15: Cochlear Limited: Overall Financials, 2016-2018
Figure 10.16: Cochlear Limited - Revenue (by Segment), 2016-2018
Figure 10.17: Cochlear Limited - Revenue (by Region), 2016-2018
Figure 10.18: Cochlear Limited - Research and Development Expense, 2016-2018
Figure 10.19: Cochlear Limited: Overall Product Portfolio
Figure 10.20: SWOT Analysis – Cochlear Limited
Figure 10.21: electroCore, Inc.: Overall Financials, 2016-2018
Figure 10.22: electroCore, Inc - Research and Development Expense, 2016-2018
Figure 10.23: electroCore, Inc.: Overall Product Portfolio
Figure 10.24: SWOT Analysis – electroCore, Inc.
Figure 10.25: Inspire Medical Systems, Inc.: Overall Financials, 2016-2018
Figure 10.26: Inspire Medical Systems, Inc. - Revenue (by Region), 2016-2018
Figure 10.27: Inspire Medical Systems, Inc - Research and Development Expense, 2016-2018
Figure 10.28: Inspire Medical Systems, Inc.: Overall Product Portfolio
Figure 10.29: SWOT Analysis – Inspire Medical Systems, Inc.
Figure 10.30: LivaNova Plc: Overall Financials, 2016-2018
Figure 10.31: LivaNova Plc - Revenue (by Segment), 2016-2018
Figure 10.32: LivaNova Plc - Revenue (by Region), 2016-2018
Figure 10.33: LivaNova, Plc - Research and Development Expense, 2016-2018
Figure 10.34: LivaNova, Plc.: Overall Product Portfolio
Figure 10.35: SWOT Analysis – LivaNova Plc
Figure 10.36: Medtronic Plc - Overall Financials, 2017-2019
Figure 10.37: Medtronic Plc - Revenue (by Segment), 2017-2019
Figure 10.38: Medtronic Plc - Revenue (by Region), 2017-2019
Figure 10.39: Medtronic Plc - Research and Development Expense, 2017-2019
Figure 10.40: Medtronic Plc – Product Portfolio for Bioelectric Medicine Market
Figure 10.41: SWOT Analysis – Medtronic Plc
Figure 10.42: MED-EL: Overall Product Portfolio
Figure 10.43: SWOT Analysis – MED-EL
Figure 10.44: Nevro Corp.: Overall Financials, 2016-2018
Figure 10.45: Nevro Corp. - Revenue (by Region), 2016-2018
Figure 10.46: Nevro Corp. - Research and Development Expense, 2016-2018
Figure 10.47: Nevro Corp.: Overall Product Portfolio
Figure 10.48: SWOT Analysis – Nevro Corp.
Figure 10.49: Nuvectra Corporation: Overall Financials, 2016-2018
Figure 9.50: Nuvectra Corporation: Revenue (by Region), 2016-2018
Figure 10.51: Nuvectra Corporation: R&D Expenditure, 2016-2018
Figure 10.52: Nuvectra Corporation: Overall Product Portfolio
Figure 10.53: SWOT Analysis –Nuvectra Corporation
Figure 10.54: NeuroMetrix, Inc.: Overall Financials, 2016-2018
Figure 10.55: NeuroMetrix, Inc.: Overall Product Portfolio
Figure 10.56: SWOT Analysis – NeuroMetrix, Inc.
Figure 10.57: Omron Corporation - Overall Financials, 2015-2017
Figure 10.58: Omron Corporation: Revenue by Segment, 2015-2017
Figure 10.59: Omron Corporation: Revenue by Region, 2015-2017
Figure 10.60: Omron Corporation: R&D Expenditure, 2015-2017
Figure 10.61: Omron Corporation - Product Portfolio for Global Bioelectric Medicine Market
Figure 10.62: SWOT Analysis – Omron Corporation
Figure 10.63: PIXIUM VISION: Overall Product Portfolio
Figure 10.64: SWOT Analysis – PIXIUM VISION
Figure 10.65: Second Sight Medical Products, Inc.: Overall Financials, 2016-2018
Figure 10.66: Second Sight Medical Products, Inc. - Research and Development Expense, 2016-2018
Figure 10.67: Second Sight Medical Products, Inc.: Overall Product Portfolio
Figure 10.68: SWOT Analysis – Second Sight Medical Products, Inc.
Figure 10.69: SetPoint Medical: Overall Product Portfolio
Figure 10.70: SWOT Analysis – SetPoint Medical
Figure 10.71: Stimwave LLC: Overall Product Portfolio
Figure 10.72: SWOT Analysis – Stimwave LLC
Figure 1: Global Bioelectric Medicine Market Snapshot
Figure 2: Market Drivers and Market Restraints
Figure 3: Competitive Scenario of Spinal Cord Stimulation Device in the Global Bioelectric Medicine Market
Figure 4: Global Bioelectric Medicine Market, 2018-2025
Figure 5: Growth Share Matrix of Products, 2018
Figure 1.1: Examples of Diseases that are Potential Target for Bioelectric Medicine
Figure 2.1: Global Bioelectric Medicine: Market Segmentation
Figure 3.1: Bioelectric Medicine Market Research Methodology
Figure 3.2: Primary Research
Figure 3.3: Secondary Research
Figure 3.4: Data Triangulation
Figure 3.5: Top-Down Approach (Segment-Wise Analysis)
Figure 3.6: Bottom-Up Approach (Segment-Wise Analysis)
Figure 3.7: Assumptions and Limitations
Figure 3.8: Considered Factors for Data Prediction and Modeling
Figure 4.1: Share of Patent by Ownership, January 2016- July 2019
Figure 5.1: Competitive Landscape
Figure 5.2: Share of Key Developments and Strategies- January 2016- July 2019
Figure 5.3: Product Launches, Approvals, and Clearances (by Company), January 2016 -July 2019
Figure 5.4: Agreements, Collaborations, Joint Ventures, and Partnership (by Company). January 2016-July 2019
Figure 5.5: Mergers and Acquisitions (by Company), January 2016–July 2019
Figure 5.6: Business Expansion (by Company), January 2016- July 2019
Figure 5.7: Market Share Analysis (by Company), for Spinal Cord Stimulation Devices in the Bioelectric Medicine Market, 2018
Figure 5.8: Market Share Analysis (by Company), for Cochlear Implant in the Global Bioelectric Medicine Market, 2018
Figure 5.9: Market Share Analysis (by Company), for Pacemaker and ICD in the Global Bioelectric Medicine Market, 2018
Figure 5.10: Growth Share Matrix for Global Implantable Bioelectric Medicine Market, by Products, 2018
Figure 6.1: Evolution of Pacemaker and ICD
Figure 6.2: FDA Approval Indications by Various Vendor Products
Figure 7.1: Segmentation of Bioelectric Medicine Market
Figure 7.2: Global Bioelectric Medicine Market, 2018-2025
Figure 7.3: Drivers, Restraints, and Opportunities of the Global Bioelectric Medicine Market
Figure 7.4: Impact Analysis
Figure 7.5: Geriatric Population (60 years and above) Worldwide in Different Regions, 2000, 2015, 2030, 2050
Figure 7.6: U.S. Annual Alzheimer’s Death Rate (per 100,000 People) by Year
Figure 8.1: Segmentation of Bioelectric Medicine Market, by Product Type
Figure 8.2: Global Bioelectric Medicine Market, by Product Type, Market Share 2018
Figure 8.3: Implantable Bioelectric Medicine in the Global Bioelectric Medicine Market, 2018 and 2025
Figure 8.4: Mechanism of Action Pacemaker
Figure 8.5: Pacemaker in the Global Bioelectric Medicine Market, 2018-2025
Figure 8.6: Mechanism Action of ICD
Figure 8.7: ICD in the Global Bioelectric Medicine Market, 2018-2025
Figure 8.8: Mechanism Action of Spinal Cord Stimulation Device
Figure 8.9: Spinal Cord Stimulation Device in the Global Bioelectric Medicine Market, 2018-2025
Figure 8.10: Mechanism of Action of Cochlear Implants
Figure 8.11: Cochlear Implant in the Global Bioelectric Medicine Market, 2018-2025
Figure 8.12: Deep Brain Stimulation Device in the Global Bioelectric Medicine Market. 2018-2025
Figure 8.13: Vagus Nerve Stimulation Device in the Global Bioelectric Medicine Market. 2018-2025
Figure 8.14: Others in the Global Bioelectric Medicine Market. 2018-2025
Figure 8.15: Non-Implantable in the Global Bioelectric Medicine Market. 2018-2025
Figure 9.1: Global Bioelectric Medicine Market Scenario, 2018
Figure 9.2: North America: Bioelectric Medicine Market, 2018-2025
Figure 9.3: North America: Market Dynamics
Figure 9.4: North America: Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.5: North America: Implantable Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.6: North America: Bioelectric Medicine Market (by Country), 2018 and 2025
Figure 9.7: Alzheimer’s Dementia in Different Age Groups in the U.S., 2018
Figure 9.8: U.S.: Bioelectric Medicine Market, 2018-2025
Figure 9.9: U.S.: Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.10: U.S.: Implantable Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.11: Canada: Bioelectric Medicine Market, 2018-2025
Figure 9.12: Canada: Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.13: Canada: Implantable Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.14: Number of People with Parkinson’s Disease in Different European Countries
Figure 9.15: Europe: Bioelectric Medicine Market, 2018-2025
Figure 9.16: Europe: Market Dynamics
Figure 9.17: Europe: Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.18: Europe: Implantable Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.19: Europe: Bioelectric Medicine Market (by Country), 2018 and 2025
Figure 9.20: Germany: Bioelectric Medicine Market, 2018-2025
Figure 9.21: Germany: Bioelectric Medicine Market (by Product Type), 2018-2025
Figure 9.22: Germany: Implantable Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.23: U.K.: Bioelectric Medicine Market, 2018-2025
Figure 9.24: U.K.: Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.25: U.K.: Implantable Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.26: France: Bioelectric Medicine Market, 2018-2025
Figure 9.27: France: Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.28: France: Implantable Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.29: Italy: Bioelectric Medicine Market, 2018-2025
Figure 9.30: Italy: Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.31: Italy: Implantable Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.32: Spain: Bioelectric Medicine Market, 2018-2025
Figure 9.33: Spain: Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.34: Spain: Implantable Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.35: Rest-of-Europe: Bioelectric Medicine Market, 2018-2025
Figure 9.36: Rest-of-Europe: Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.37: Rest-of-Europe: Implantable Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.38: Asia-Pacific: Bioelectric Medicine Market, 2018-2025
Figure 9.39: Asia-Pacific: Market Dynamics
Figure 9.40: Asia-Pacific: Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.41: Asia-Pacific: Implantable Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.42: Asia-Pacific: Bioelectric Medicine Market (by Country), 2018 and 2025
Figure 9.43: Japan: Bioelectric Medicine Market, 2018-2025
Figure 9.44: Japan: Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.45: Japan: Implantable Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.46: China: Bioelectric Medicine Market, 2018-2025
Figure 9.47: China: Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.48: China: Implantable Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.49: India: Bioelectric Medicine Market, 2018-2025
Figure 9.50: India: Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.51: India: Implantable Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.52: South Korea: Bioelectric Medicine Market, 2018-2025
Figure 9.53: South Korea: Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.54: South Korea: Implantable Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.55: Rest-of-Asia-Pacific: Bioelectric Medicine Market, 2018-2025
Figure 9.56: Rest-of-Asia-Pacific: Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.57: Rest-of-Asia-Pacific: Implantable Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.58: Latin America: Bioelectric Medicine Market, 2018-2025
Figure 9.59: Latin America: Market Dynamics
Figure 9.60: Latin America: Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.61: Latin America: Implantable Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.62: Latin America: Bioelectric Medicine Market (by Country), 2018 and 2025
Figure 9.63: Brazil: Bioelectric Medicine Market, 2018-2025
Figure 9.64: Brazil: Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.65: Brazil: Implantable Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.66: Mexico: Bioelectric Medicine Market, 20182025
Figure 9.67: Mexico: Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.68: Mexico: Implantable Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.69: Rest-of-Latin America: Bioelectric Medicine Market, 2018-2025
Figure 9.70: Rest-of-Latin America: Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.71: Rest-of-Latin America: Implantable Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.72: Middle East and Africa: Bioelectric Medicine Market, 2018-2025
Figure 9.73: Middle East and Africa: Market Dynamics
Figure 9.74: Middle East and Africa: Bioelectric Medicine Market (by Product), 2018-2025
Figure 9.75: Middle East and Africa: Implantable Bioelectric Medicine Market (by Product), 2018-2025
Figure 10.1: Total Number of Companies Profiles
Figure 10.2: Abbott Laboratories: Overall Financials, 2016-2018
Figure 10.3: Abbott Laboratories - Revenue (by Segment), 2016-2018
Figure 10.4: Abbott Laboratories - Revenue (by Region), 2016-2018
Figure 10.5: Abbott Laboratories - Research and Development Expense, 2016-2018
Figure 10.6: Abbott Laboratories: Overall Product Portfolio
Figure 10.7: SWOT Analysis – Abbott Laboratories
Figure 10.8: Boston Scientific Corporation: Overall Financials, 2016-2018
Figure 10.9: Boston Scientific Corporation - Revenue (by Segment), 2016-2018
Figure 10.10: Boston Scientific Corporation - Research and Development Expense, 2016-2018
Figure 10.11: Boston Scientific Corporation: Overall Product Portfolio
Figure 10.12: SWOT Analysis – Boston Scientific Corporation
Figure 10.13: BIOTRONIK SE & Co. KG: Overall Product Portfolio
Figure 10.14: SWOT Analysis – BIOTRONIK SE & Co. KG
Figure 10.15: Cochlear Limited: Overall Financials, 2016-2018
Figure 10.16: Cochlear Limited - Revenue (by Segment), 2016-2018
Figure 10.17: Cochlear Limited - Revenue (by Region), 2016-2018
Figure 10.18: Cochlear Limited - Research and Development Expense, 2016-2018
Figure 10.19: Cochlear Limited: Overall Product Portfolio
Figure 10.20: SWOT Analysis – Cochlear Limited
Figure 10.21: electroCore, Inc.: Overall Financials, 2016-2018
Figure 10.22: electroCore, Inc - Research and Development Expense, 2016-2018
Figure 10.23: electroCore, Inc.: Overall Product Portfolio
Figure 10.24: SWOT Analysis – electroCore, Inc.
Figure 10.25: Inspire Medical Systems, Inc.: Overall Financials, 2016-2018
Figure 10.26: Inspire Medical Systems, Inc. - Revenue (by Region), 2016-2018
Figure 10.27: Inspire Medical Systems, Inc - Research and Development Expense, 2016-2018
Figure 10.28: Inspire Medical Systems, Inc.: Overall Product Portfolio
Figure 10.29: SWOT Analysis – Inspire Medical Systems, Inc.
Figure 10.30: LivaNova Plc: Overall Financials, 2016-2018
Figure 10.31: LivaNova Plc - Revenue (by Segment), 2016-2018
Figure 10.32: LivaNova Plc - Revenue (by Region), 2016-2018
Figure 10.33: LivaNova, Plc - Research and Development Expense, 2016-2018
Figure 10.34: LivaNova, Plc.: Overall Product Portfolio
Figure 10.35: SWOT Analysis – LivaNova Plc
Figure 10.36: Medtronic Plc - Overall Financials, 2017-2019
Figure 10.37: Medtronic Plc - Revenue (by Segment), 2017-2019
Figure 10.38: Medtronic Plc - Revenue (by Region), 2017-2019
Figure 10.39: Medtronic Plc - Research and Development Expense, 2017-2019
Figure 10.40: Medtronic Plc – Product Portfolio for Bioelectric Medicine Market
Figure 10.41: SWOT Analysis – Medtronic Plc
Figure 10.42: MED-EL: Overall Product Portfolio
Figure 10.43: SWOT Analysis – MED-EL
Figure 10.44: Nevro Corp.: Overall Financials, 2016-2018
Figure 10.45: Nevro Corp. - Revenue (by Region), 2016-2018
Figure 10.46: Nevro Corp. - Research and Development Expense, 2016-2018
Figure 10.47: Nevro Corp.: Overall Product Portfolio
Figure 10.48: SWOT Analysis – Nevro Corp.
Figure 10.49: Nuvectra Corporation: Overall Financials, 2016-2018
Figure 9.50: Nuvectra Corporation: Revenue (by Region), 2016-2018
Figure 10.51: Nuvectra Corporation: R&D Expenditure, 2016-2018
Figure 10.52: Nuvectra Corporation: Overall Product Portfolio
Figure 10.53: SWOT Analysis –Nuvectra Corporation
Figure 10.54: NeuroMetrix, Inc.: Overall Financials, 2016-2018
Figure 10.55: NeuroMetrix, Inc.: Overall Product Portfolio
Figure 10.56: SWOT Analysis – NeuroMetrix, Inc.
Figure 10.57: Omron Corporation - Overall Financials, 2015-2017
Figure 10.58: Omron Corporation: Revenue by Segment, 2015-2017
Figure 10.59: Omron Corporation: Revenue by Region, 2015-2017
Figure 10.60: Omron Corporation: R&D Expenditure, 2015-2017
Figure 10.61: Omron Corporation - Product Portfolio for Global Bioelectric Medicine Market
Figure 10.62: SWOT Analysis – Omron Corporation
Figure 10.63: PIXIUM VISION: Overall Product Portfolio
Figure 10.64: SWOT Analysis – PIXIUM VISION
Figure 10.65: Second Sight Medical Products, Inc.: Overall Financials, 2016-2018
Figure 10.66: Second Sight Medical Products, Inc. - Research and Development Expense, 2016-2018
Figure 10.67: Second Sight Medical Products, Inc.: Overall Product Portfolio
Figure 10.68: SWOT Analysis – Second Sight Medical Products, Inc.
Figure 10.69: SetPoint Medical: Overall Product Portfolio
Figure 10.70: SWOT Analysis – SetPoint Medical
Figure 10.71: Stimwave LLC: Overall Product Portfolio
Figure 10.72: SWOT Analysis – Stimwave LLC
